Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
2
×
fda
2
×
life sciences
national blog main
alirocumab
alnylam pharmaceuticals
amgen
biotech ipos
boston
deals
dyne therapeutics
evolocumab
inclisiran
metacrine
myotonic dystrophy type 1
national top stories
new york
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
pcsk9
pcsk9 inhibitors
rare disease drugs
rare diseases
regeneron pharmaceuticals
rna interference
salk institute
san diego blog main
san diego top stories
sanofi
the medicines company
ulcerative colitis
What
brings
company
drug
2
×
medicines
acquire
agreed
billion
cash
cholesterol
compound
deal
developing
disorders
dyne
dyne’s
fda
genetic
ipo
medco
million
muscle
muscular
new
novartis
poised
preclinical
raised
rare
ready
stage
therapeutics
topped
upsized
wave
Language
unset
2
×
Current search:
company���s
×
drug
×
unset
×
fda
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B